Taj Pharma’s Strategic Expansion in High-Value Pharmaceutical Portfolios

As one of the most trusted global pharmaceutical manufacturers, Taj Pharma continues to strengthen its footprint across the Philippines and broader APAC region, offering world-class formulations, robust regulatory dossiers, and high-capacity manufacturing aligned with WHO-GMP, PIC/S, and ISO 9001:2018 standards.

Our expanding product basket includes next-generation therapeutics across diabetes, cardiology, gastroenterology, neuropathy, and hepatology, backed by complete regulatory support for fast-track registration.


Comprehensive APAC Product Portfolio (Philippines Focus)

Regulatory-Ready Portfolio for Fast Market Entry

Below is the detailed table requested:

Product NameTherapeutic CategoryACTD DossiersCOPPBCS Class
Semaglutide 3 / 7 / 14 mg TabletAntidiabetic (GLP-1 RA)Ready/Under DevelopmentAvailableClass III
Dapagliflozin + Sitagliptin + Metformin (5/50/500 mg & 10/100/1000 mg)Antidiabetic (SGLT2i + DPP4i + Metformin)ReadyAvailableClass III
Pregabalin 75 mg + Benfotiamine 300 mg + Alpha Lipoic Acid 300 mg + Methylcobalamin 0.75 mg TabletNeuropathic PainReadyAvailableClass II / III
Bexagliflozin 20 mg TabletAntidiabetic (SGLT2i)ReadyAvailableClass I
Sotagliflozin 200 mg & 400 mg TabletDual SGLT1/2 InhibitorReady/Under DevelopmentOn RequestClass I
Bexagliflozin + Metformin TabletAntidiabetic (Fixed Dose Combination)Under DevelopmentOn RequestClass I / III
Sotagliflozin + Metformin TabletAntidiabetic (FDC)Under DevelopmentOn RequestClass I / III
Tegoprazan 50 mg TabletGastric Acid Suppressant (P-CAB)ReadyAvailableClass I
Zastaprazan 20 mg TabletP-CAB (Gastroenterology)Under DevelopmentOn RequestClass I
Obeticholic Acid 5 mg / 10 mg TabletHepatology (PBC)ReadyAvailableClass II
Agomelatine 25 mg TabletAntidepressant (Melatonergic)ReadyAvailableClass II

Taj Pharma’s Leadership in the Philippine & APAC Pharmaceutical Landscape

A Growing Demand for High-Quality, WHO-GMP Compliant Products

Across the APAC region—particularly the Philippines, Vietnam, Cambodia, Indonesia, and Myanmar—regulators increasingly demand trusted international manufacturers with stringent compliance systems. Taj Pharma addresses this demand through:

  • End-to-end ACTD dossier support
  • WHO-GMP, PIC/S, GLP certified facilities
  • Fast-track COPP issuance for priority products
  • Robust QMS aligned with global regulatory expectations
  • Regulatory, technical, and commercial partnership models

This ensures healthcare authorities and distributors in the APAC region receive consistent quality, regulatory reliability, and competitive pricing, setting Taj Pharma apart as a preferred supplier.


High-Value Products Driving Strong Market Growth

1. Advanced Diabetes Portfolio Empowering APAC Healthcare Systems

The APAC region faces one of the world’s fastest-growing diabetes populations, elevating demand for modern oral antidiabetics such as GLP-1 receptor agonists, SGLT2 inhibitors, and DPP4 inhibitors.

Semaglutide Tablets (3 / 7 / 14 mg)

A breakthrough in Type 2 diabetes management, Semaglutide oral tablets offer improved glycemic control and weight management. Taj Pharma is among few with:

  • Scaled production capability
  • ACTD dossier support
  • Stability zone IVB data

Bexagliflozin 20 mg & Sotagliflozin 200/400 mg

These next-gen SGLT2 inhibitors deliver:

  • Lowered HbA1c
  • Cardiovascular benefits
  • Superior tolerability profiles

With large-scale SGLT2 manufacturing expertise, Taj Pharma brings cost-effective, high-quality alternatives to APAC markets.

Triple Combination Antidiabetic Tablet

Dapagliflozin + Sitagliptin + Metformin offers:

  • Multi-pathway glycemic control
  • High patient compliance
  • Strong commercial potential in APAC markets

2. Neuropathy Segment: Complete FDC Solutions

The combination of Pregabalin + Benfotiamine + ALA + Methylcobalamin addresses diabetic neuropathy with a multi-therapeutic approach and remains a top-imported segment in the Philippines, giving Taj Pharma a strong commercial edge.

3. Gastroenterology Excellence: P-CAB Leadership

Tegoprazan 50 mg & Zastaprazan 20 mg

P-CABs represent the next era of acid suppression therapy, outperforming PPIs in:

  • Speed of onset
  • Night-time acid control
  • Ulcer healing efficacy

Their growing market adoption in Korea, Japan, and now the Philippines positions Taj Pharma as a strategic early entrant.

4. Liver Disease Therapies for a Growing APAC Need

Obeticholic Acid (5 mg / 10 mg)

Used for Primary Biliary Cholangitis (PBC), this niche hepatology product has strong demand across APAC due to increasing liver disease prevalence.

Taj Pharma supports:

  • Full ACTD/CTD documentation
  • Bioequivalence support
  • Long-term stability data

5. Psychiatry & CNS Care

Agomelatine 25 mg Tablet

A unique melatonergic antidepressant with low side-effect profile, perfectly aligned with rising mental health care priorities across the region.


Why Taj Pharma Dominates the APAC Regulatory & Supply Chain Ecosystem

Unmatched Regulatory Strength

We provide:

  • ACTD-ready dossiers for all major APAC markets
  • BE (Bioequivalence) support where necessary
  • Site master files and CPP/COPP issuance
  • Electronic CTD submissions

Advanced Manufacturing Ecosystem

Our facilities at Sarigam, Gujarat, India operate with:

  • Modern automation & high-volume lines
  • Cleanroom standards compliant with WHO & PIC/S
  • In-house microbiology, analytical & stability labs

Commercial Advantages for APAC Importers

  • Competitive pricing through large-scale production
  • Flexible MOQs and long-term supply contracts
  • Private-label and in-licensing arrangements

Market Impact in the Philippines

The Philippines has shown exponential growth in:

  • Cardiometabolic therapy demand
  • New-generation gastroenterology molecules
  • Chronic disease management formulations

Taj Pharma’s strong dossier readiness and rapid regulatory turnaround make us one of the most reliable partners for Filipino distributors, hospitals, tender bodies, and government procurement units.


Taj Pharma – Powering the Future of APAC Market Healthcare

With deep expertise in regulatory filings, high-quality manufacturing, and commercial-scale supply, Taj Pharma stands as a leading force shaping the pharmaceutical landscape across the Philippines and APAC region.

Our expanding product line—featuring next-generation antidiabetic agents, P-CABs, CNS products, and hepatology therapies—positions us to meet evolving healthcare demands with unmatched quality and reliability.